Dr. med h.c. Beat Löffler, MA studied after a study visit in the USA, Philosophy, Communication Sciences and Politics at the Free University in Berlin, graduating with a Master of Arts.(MA)
In 2014 he received an MD h.c. from the University of Basel. He founded the European Foundation for Clinical Nanomedicine in 2007 together with Prof. Patrick Hunziker. The aim of the foundation is the research and development of nanomedicine with regard to its use as an innovative medical technology, better medical care in the future and the establishing an international network in nanomedicine and related fields.  He leads the neutral high-level debate platform organized by the nonprofit foundation, which also a meeting place for the international regulatory authorities (FDA, EMA) in the field of nanotechnologies in health.  Presently CLINAM is the largest network for worldwide clinical nanomedicine meetings and has become a gathering between all stakeholders in Nanomedicine and related fields. The foundation launched the European Journal of Nanomedicine PRNANO. He founded together with Prof. Patrick Hunziker the European Society for Nanomedicine and the International Society for Nanomedicine, which realizes every year a Nanomedicine Summer school in difffernt countries. He was head of dissemination of the EU-funded NanoAthero project and five other framework programmes. He cooperates regularly in Projects of the European Materials Research Society in Strasbourg, France.

Patrick Hunziker has studied Medicine at the University of Zurich, Switzerland and has received a doctoral decree based on thesis work in experimental immunology from the University of Zurich in 1989. He started his research with experimental hematology and throughout his career remains involved in clinical as well as in laboratory research. He earned specialist degrees in Internal Medicine, Cardiology and Intensive Care Medicine. Professional activities in the Europe, the U.S., Africa and China gave him a broad insight into the needs for the medicine of the future. As a fellow at the Massachusetts General Hospital, Harvard Medical School, he worked on imaging technologies in humans and in animals in a joint project with the Massachusetts Institute of Technology, Cambridge and in animal models of acute myocardial infarction including early efforts toward cell transplantation in myocardial infarction. Focusing his research on application of high-tech methods to improved diagnosis and therapy, he became lecturer at the University of Basel in the field of cardiology based on his work on innovative imaging modalities based on computer vision, which led to the prize of the Swiss Heart Foundation, the most prestigious prize in cardiology in Switzerland. He also won the Pfizer research prize for his work in improved diagnosis of cardiovascular disease. In 2008, he received the title of Professor from the University of Basel. He remains active in the field of computational modeling, computational imaging and artificial intelligence. In cardiovascular disease, he pioneered the use of catheter based mechanical heart pump support in cardiogenic shock. Foreseeing in the late 90’ies that significant advances in medicine disease would be brought by the advances in the nanoscience, he became involved in medical applications of nanoscience in the late nineties, combining his experience in experimental research and his knowledge in the problems of clinical medicine, as the physician at the Swiss National Center of Competence Nanotechnology in 2001. His nanoscience research has been cited as a “Nanoscience milestone of the year” by MIT technology review in 2007 for the development of nanosize polymer carriers with switchable functionality. He has worked in the medical applications of atomic force microscopy, nano-optics, micro/nanofluidics, nanomechanical sensors and polymer nanocarriers for targeting, including cell-culture and animal research in transgenic animal models. Applying his research to poverty diseases, he has, led one of the largest epidemiologic field trials on Schistosomiasis in Congo, Africa. He is the co-founding president of the International Society of Nanomedicine, has initiated together with Dr. Beat Löffler (CLINAM Foundation for clinical Nanomedicine) the annual European and Global Summit for Clinical Nanomedicine, the leading event in its field, and is clinically active as deputy head of the Clinic for Intensive Care Medicine at the University Hospital of Basel, Switzerland. He is frequently invited as speaker to international conferences in the topic of nanomedicine and has gained a high visibility (google: ”Hunziker Nano”) within the field. He was invited to shape the future research policy of the European Commission in the field of Nanomedicine and has been member of various strategic committees on a university, national and continental level. Patrick Hunziker has authored >230 scientific publications, has received >13000 citations and has a current Hirsch Index of 52, as shown in https://scholar.google.com/citations?user=vc6l6sAAAAAJ&hl=de&oi=ao